Chung, A., Anderson, L., Foster, L., Chaulagain, C., Pettijohn, E. M., Cowan, A. J., Costello, C., Larson, S., Sborov, D., Shain, K., Silbermann, R., Voorhees, P., Gandhi, M., Krevvata, M., Ngo, M., Patel, S., Khare, V., Cortoos, A., Lin, T., Badros, A. (2025). Minimal residual disease dynamics in post-transplant patients with newly diagnosed multiple myeloma who received daratumumab plus lenalidomide versus lenalidomide alone as maintenance therapy in the auriga study. Blood. https://doi.org/10.1182/blood-2025-97